论文部分内容阅读
随着人类社会对卫生保健的需求日益增加,药品和其他医疗措施消耗费用迅猛增长已经成为妨碍各国医疗事业发展的沉重负担。如美国医疗保健费用近年高达6000亿美元,约占国民生产总值(GNP)的11％～16％,大多数欧洲国家约占7％～9％,日本约占14.9％;目前我国全社会保健总费用约600亿元人民币,公费劳保医疗费用的年增长率高达23.2％,明显高于国家财政收入的年增长率(约10％),但人均水平低、管理失控、浪费严重等问题相当严重。同时,近年价格昂贵的进口药大量充斥国内市场,如不采取有力的对策,药物治疗费用将可能成倍增长。
With the increasing demand for health care in human society, the rapid increase in the cost of medicines and other medical measures has become a heavy burden that hinders the development of medical services in all countries. For example, the cost of health care in the United States has reached 600 billion U.S. dollars in recent years, accounting for 11% to 16% of the gross national product (GNP). Most European countries account for 7% to 9%, and Japan accounts for 14.9%; The total cost is about 60 billion yuan. The annual growth rate of public health insurance medical expenses is as high as 23.2%, which is obviously higher than the annual growth rate of national fiscal revenue (about 10%). However, the problem of low per capita level, out of control management, and serious waste is quite serious. . At the same time, in recent years, expensive imported drugs have flooded the domestic market in large numbers. If no effective countermeasures are taken, drug treatment costs may multiply exponentially.